On October 16, Shenzhen Economic Daily (B03) published a report titled “Great Changes in Sanjiu Pharmaceutical since Restructured by CR” in a column designated for “Open Day for Investors in Listed Companies” co-sponsored by Shenzhen Stock Exchange and Shenzhen Securities Regulatory Bureau.

The report outlines the rapid development achieved by the enterprise since the asset restructure with CR in 2008. According to the report, the company established its industrial development strategy, adopted CR’s 6S Management System, completed the debt repayment and equity reform, improved the corporate governance structure and established OTC and prescribed Chinese medicine as its main businesses. Those strategic measures have substantially helped the enterprise to realize an average compound annual growth rate of 25% and a breakthrough net profit growth rate of 30% for the past five years.

Please click here for full text of the report: http://szsb.sznews.com/html/2013-10/16/content_2651597.htm